Boost Your Brain! Cerebrolysin: The Pig Brain Peptide Nootropic & Its Uses, Side Effects, & Dosing
A short solo talk in which Dr. Michael Moeller gives his understanding of Cerebrolysin, covering its proposed mechanisms, uses, side effects, his dosing, and contraindications.
Key moments
Tap a moment to play the video from there.
- 0:00Why he is covering CerebrolysinMoeller says viewers keep asking about it and introduces it as the brain-derived peptide used as a nootropic. He asks viewers to share their own experience.
- 0:32Origin and blood-brain barrierHe says the growth factors are purified from brain tissue and that the mixture is small enough to cross the blood-brain barrier. He adds that BDNF was first found in brain tissue of non-human origin.
- 1:30Lactic acid and inflammationMoeller says it seems to lower lactic acid, which he links to reduced brain inflammation. He describes this as his understanding of the metabolism involved.
- 2:00Working with less oxygenHe says it appears to let neurons function with less oxygen and suggests this fits low-oxygen conditions such as Alzheimer's, vascular dementia and stroke. He also mentions an effect on apoptosis.
- 3:02What it is used forHe says a European drug company uses it for ischemic stroke, Alzheimer's and dementia, where most trials are. He says his own interest is the nootropic use, including less fatigue and brain fog.
- 4:15Side effects and sourcingMoeller warns about contaminated peptides bought online. He mentions weight loss at higher doses in early trials and a 3 to 5 percent chance of headache, dizziness, anxiety or agitation.
- 5:32His dosing approachHe describes 1 ml subcutaneous injections daily for about 30 days, or 5 days on and 2 days off. He notes most studies used intravenous dosing.
- 6:04ContraindicationsHe lists allergy, cancer and possibly autoimmune disease as reasons for caution. He ties the cancer concern to growth factors.
- 6:34Studies and closing viewHe points to PubMed references he reviewed and calls the area promising for neurodegeneration. He mentions Alzheimer's studies that showed help with arithmetic and cautions it may only restore baseline.
What the video says
Dr. Michael Moeller, speaking alone to camera, says he has been getting many questions about Cerebrolysin, which he describes as a brain-derived peptide used as a nootropic. He explains that it is made of growth factors purified from brain tissue and says it is small enough to cross the blood-brain barrier. He also notes that brain-derived neurotrophic factor was first discovered in brain tissue of non-human origin.
Much of the talk is his reasoning about how it might work. He says it seems to lower lactic acid, which he links to less brain inflammation, and that it seems to let the brain operate with less oxygen. He connects that to conditions with low oxygen such as Alzheimer's, vascular dementia and stroke. He also mentions that it appears to inhibit apoptosis, which he says could be a problem for anyone with a tumor or cancer. He frames these points as hypotheses and says he is not fully certain of the details.
On use, Moeller says it is more popular outside the United States, and that a European drug company uses it for ischemic stroke, Alzheimer's and dementia, where most clinical trials are happening. For nootropic purposes, he says he has used it himself and with patients and received good feedback, including less fatigue and brain fog. He also cites a study that reported more alpha wave activity. On safety, he stresses sourcing, warning that peptides bought online may be contaminated. He mentions weight loss at higher doses in early trials, and a 3 to 5 percent chance of effects such as headache, dizziness, anxiety and agitation, which he felt briefly himself.
For dosing, he describes giving 1 ml subcutaneous injections daily for about 30 days, or a 5 days on, 2 days off pattern, while noting most studies used intravenous dosing soon after ischemic events. He lists allergy, cancer and possibly autoimmune conditions as contraindications, and closes by pointing to PubMed references and calling the field promising.
On each compound
Cerebrolysin0:00
Moeller describes it as a brain-derived peptide made of purified growth factors that crosses the blood-brain barrier. He says he and some patients have used it as a nootropic with good feedback, and covers his dosing, side effects and contraindications.
See how your DNA reads CerebrolysinWhat this video doesn’t settle
- Moeller's mechanism explanations about lactic acid, oxygen use and apoptosis are offered as his own reasoning, with no data shown.
- His account of benefits in himself and patients is anecdotal, with no control group or measured outcomes.
- The studies he cites are named only by PubMed ID in passing, so the video does not establish how strong or consistent the evidence is.
Questions this video answers
What is Cerebrolysin according to Dr. Moeller?
Moeller describes it as a mix of growth factors purified from brain tissue, used as a nootropic. He says it is small enough to cross the blood-brain barrier.
What dose of Cerebrolysin does Dr. Moeller use?
He says he gives his patients 1 ml subcutaneous injections daily for about 30 days, or a 5 days on, 2 days off pattern. He notes that most studies used intravenous administration.
What side effects of Cerebrolysin does Moeller mention?
He mentions weight loss at higher doses in early trials and a 3 to 5 percent chance of effects like headache, dizziness, anxiety and agitation. He says he felt some anxiety and agitation himself after a couple of hours.
Who should avoid Cerebrolysin, according to this video?
Moeller says it is probably not a good idea with an allergy, with cancer because of the growth factors, or possibly with autoimmune conditions because it is purified from a non-human source. He says the autoimmune point is hard to tell.
Video by Dr. Michael Moeller on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
